CRDF Q1 2020 Earnings — Cardiff Oncology, Inc. Revenue & Financial Results | Market Cap Arena

CRDFCardiff Oncology, Inc.

$133M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$68,000-58.0% YoY

Gross Profit

$68,000100.0% margin

Operating Income

-$4M-6064.7% margin

Net Income

-$4M-6013.2% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

-26.5%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$177,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$6M

Stockholders' Equity

$6M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68,000	$162,000	-58.0%
Gross Profit	$68,000	-$2M	+102.7%
Operating Income	-$4M	-$4M	-4.1%
Net Income	-$4M	-$4M	-4.7%